LEVELS OF HDL CHOLESTEROL IN ISCHEMIC STROKE PATIENTS AND DISEASE OUTCOME IN 2 WEEKS
Main Article Content
Keywords
HDL cholesterol, ischemic stroke, lipid profile, neurological outcome, prognosis
Abstract
: Ischemic stroke remains a significant factor leading to disabilities and death, and new research indicates that lipid disorders, mainly low HDL cholesterol, might be a determining factor for the extent of stroke and the patient's recovery within the first hours.
Objective: To find out the level of HDL cholesterol in patients with an ischemic stroke and measure the relationship of these levels with the clinical outcomes after two weeks.
Methods: This observational study was carried out at HBS Medical and Dental College Islamabad, from September 2024 to February 2025. Patients aged 18 years and above with a confirmed diagnosis of ischemic stroke were included in the study. HDL-C, along with other lipid parameters, was checked within 24 hours of the patient's admission. Neurological status was determined with the aid of NIHSS, and the two-week results were measured through the modified Rankin Scale (mRS). Statistical analyses comprised group comparisons and logistic regression.
Results: Elevated HDL-C levels were very significantly linked to positive outcomes at two weeks. Individuals who experienced bad recovery were found to have substantially lower levels of HDL-C, and the regression analysis revealed that HDL-C was the only predictor of early functional improvement.
Conclusion: HDL cholesterol represents one of the significant prognostic factors in the first phase of ischemic stroke recovery.
References
2. Johannesen CD, Mortensen MB, Langsted A, Nordestgaard BG. ApoB and non‐HDL cholesterol versus LDL cholesterol for ischemic stroke risk. Annals of Neurology. 2022 Sep;92(3):379-89.
3. Liu H, Liu K, Pei L, Li S, Zhao J, Zhang K, Zong C, Zhao L, Fang H, Wu J, Sun S. Atherogenic index of plasma predicts outcomes in acute ischemic stroke. Frontiers in Neurology. 2021 Oct 11;12:741754.
4. Sabahi M, Ahmadi SA, Kazemi A, Mehrpooya M, Khazaei M, Ranjbar A, Mowla A. The effect of Oleoylethanolamide (OEA) add‐on treatment on inflammatory, oxidative stress, lipid, and biochemical parameters in the acute ischemic stroke patients: randomized double‐blind placebo‐controlled study. Oxidative Medicine and Cellular Longevity. 2022;2022(1):5721167.
5. Kalav S, Bektas H, Ünal A. Effects of Chronic Care Model‐based interventions on self‐management, quality of life and patient satisfaction in patients with ischemic stroke: A single‐blinded randomized controlled trial. Japan Journal of Nursing Science. 2022 Jan;19(1):e12441.
6. Adiguzel A, Arsava EM, Topcuoglu MA. Temporal course of peripheral inflammation markers and indexes following acute ischemic stroke: prediction of mortality, functional outcome, and stroke-associated pneumonia. Neurological Research. 2022 Mar 4;44(3):224-31.
7. Ma X, Yang J, Wang X, Wang X, Chai S. The clinical value of systemic inflammatory response index and inflammatory prognosis index in predicting 3-month outcome in acute ischemic stroke patients with intravenous thrombolysis. International Journal of General Medicine. 2022 Oct 22;15:7907.
8. Zhou Y, Zhang Y, Cui M, Zhang Y, Shang X. Prognostic value of the systemic inflammation response index in patients with acute ischemic stroke. Brain and Behavior. 2022 Jun;12(6):e2619.
9. Sun W, Huang S, Yang X, Luo Y, Liu L, Wu D. The oral microbiome of patients with ischemic stroke predicts their severity and prognosis. Frontiers in Immunology. 2023 Apr 17;14:1171898.
10. Karimi E, Khorvash F, Arab A, Sepidarkish M, Saadatnia M, Amani R. The effects of royal jelly supplementation on oxidative stress, inflammatory mediators, mental health, cognitive function, quality of life, and clinical outcomes of patients with ischemic stroke: study protocol for a randomized controlled trial. BMC Nutrition. 2023 Feb 16;9(1):32.
11. Wang C, Du Z, Ye N, Shi C, Liu S, Geng D, Sun Y. Hyperlipidemia and hypertension have synergistic interaction on ischemic stroke: insights from a general population survey in China. BMC Cardiovascular Disorders. 2022 Feb 13;22(1):47.
12. Li Y, Zhang M, Xue M, Liu D, Sun J. Elevated monocyte-to-HDL cholesterol ratio predicts post-stroke depression. Frontiers in Psychiatry. 2022 Jul 22;13:902022.
13. Nam KW, Kwon HM, Lee YS. High triglyceride-glucose index is associated with early recurrent ischemic lesion in acute ischemic stroke. Scientific Reports. 2021 Jul 28;11(1):15335.
14. Xu C, Cai L, Yi T, Yi X, Hu Y. Neutrophil‐to‐lymphocyte ratio is associated with stroke progression and functional outcome in patients with ischemic stroke. Brain and Behavior. 2023 Nov;13(11):e3261.
15. Gasbarrino K, Di Iorio D, Daskalopoulou SS. Importance of sex and gender in ischaemic stroke and carotid atherosclerotic disease. European Heart Journal. 2022 Feb 7;43(6):460-73.
16. El-Rakabawy OM, Elkholy AA, Mahfouz AA, Abdelsalam MM, El Wakeel LM. Curcumin supplementation improves the clinical outcomes of patients with diabetes and atherosclerotic cardiovascular risk. Scientific Reports. 2025 Aug 4;15(1):28358.
17. Schubert J, Leosdottir M, Lindahl B, Westerbergh J, Melhus H, Modica A, Cater N, Brinck J, Ray KK, Hagström E. Intensive early and sustained lowering of non–high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry. European Heart Journal. 2024 Oct 14;45(39):4204-15.
18. Dawson J, Bejot Y, Christensen LM, De Marchis GM, Dichgans M, Hagberg G, Heldner MR, Milionis H, Li L, Pezzella FR, Taylor Rowan M. European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack. European Stroke Journal. 2022 Sep;7(3):I–XLI.
